» Articles » PMID: 20649963

Analysis of the Copy Number Profiles of Several Tumor Samples from the Same Patient Reveals the Successive Steps in Tumorigenesis

Overview
Journal Genome Biol
Specialties Biology
Genetics
Date 2010 Jul 24
PMID 20649963
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

We present a computational method, TuMult, for reconstructing the sequence of copy number changes driving carcinogenesis, based on the analysis of several tumor samples from the same patient. We demonstrate the reliability of the method with simulated data, and describe applications to three different cancers, showing that TuMult is a valuable tool for the establishment of clonal relationships between tumor samples and the identification of chromosome aberrations occurring at crucial steps in cancer progression.

Citing Articles

Cancer phylogenetic inference using copy number alterations detected from DNA sequencing data.

Lu B Cancer Pathog Ther. 2025; 3(1):16-29.

PMID: 39872371 PMC: 11764021. DOI: 10.1016/j.cpt.2024.04.003.


DICE: fast and accurate distance-based reconstruction of single-cell copy number phylogenies.

Weiner S, Bansal M Life Sci Alliance. 2024; 8(3).

PMID: 39667913 PMC: 11638338. DOI: 10.26508/lsa.202402923.


A Novel Gene Expression Scoring System Predicts Recurrence in Non-Muscle-Invasive Bladder Cancer Patients.

Kayama E, Uemura M, Onagi A, Meguro S, Ogawa S, Yaginuma K Cancer Med. 2024; 13(22):e70349.

PMID: 39540204 PMC: 11561421. DOI: 10.1002/cam4.70349.


Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.

Hasan A, Cremaschi P, Wetterskog D, Jayaram A, Wong S, Williams S Nat Commun. 2023; 14(1):4823.

PMID: 37563129 PMC: 10415299. DOI: 10.1038/s41467-023-40315-9.


CNETML: maximum likelihood inference of phylogeny from copy number profiles of multiple samples.

Lu B, Curtius K, Graham T, Yang Z, Barnes C Genome Biol. 2023; 24(1):144.

PMID: 37340508 PMC: 10283241. DOI: 10.1186/s13059-023-02983-0.


References
1.
Hwang E, DeVries S, Chew K, Moore 2nd D, Kerlikowske K, Thor A . Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res. 2004; 10(15):5160-7. DOI: 10.1158/1078-0432.CCR-04-0165. View

2.
van Tilborg A, De Vries A, de Bont M, Groenfeld L, van der Kwast T, Zwarthoff E . Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet. 2000; 9(20):2973-80. DOI: 10.1093/hmg/9.20.2973. View

3.
Mullighan C, Phillips L, Su X, Ma J, Miller C, Shurtleff S . Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008; 322(5906):1377-80. PMC: 2746051. DOI: 10.1126/science.1164266. View

4.
Heidenblad M, Lindgren D, Jonson T, Liedberg F, Veerla S, Chebil G . Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Med Genomics. 2008; 1:3. PMC: 2227947. DOI: 10.1186/1755-8794-1-3. View

5.
Bulashevska S, Szakacs O, Brors B, Eils R, Kovacs G . Pathways of urothelial cancer progression suggested by Bayesian network analysis of allelotyping data. Int J Cancer. 2004; 110(6):850-6. DOI: 10.1002/ijc.20180. View